Search NASA⌕ Search

SEARCH · Search NASA

Results for “HRP”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11
All sourcesNASA NTRSDOE OSTI
NASA NTRS2018

Cross-Cutting Computational Modeling Project: Integrative Modeling Approach

A wide range of computational models and analyses have been applied to spaceflight risk assessment and countermeasure development. The benefits of using computational modeling to enhance Human Research Program (HRP) goals include the ability to mathematically represent physiological systems, integrate multiple, discrete experimental measures, span multiple temporal and spatial scales, determine important factors within the system and provide estimates of unmeasurable quantities. In the area of application, computational models provide a means of developing simulations to test hypotheses, determining key factors of the system to aid experimental design and bridging gaps in sparse data by mathematically simulating large populations. Specifically, computational models and their supporting analysis tools have the proven potential to integrate analyses of risk factors to enhance mission planning and preparation capabilities and to inform spacecraft design and countermeasure development. Appropriately applied, computational models may allow intelligent, unbiased physiological parameter assessment to enable hypothesis testing and model based design of experiments. HRP recently formed the Computational Modeling Project (CMP), managed out of Glenn Research Center, as a cross-cutting activity aimed at leveraging the growing power and acceptance of computational modeling in informing clinical, physiological, and biological studies. This presentation will provide an overview of the challenges and opportunities in implementing various forms of computational models in support of the HRPs path to risk reduction.

biomechanics↗
NASA NTRS2020

MEDPRAT-SEL: Medical Resource Set Selector Searching High-Dimensionality Space

NASA Human Research Program's (HRP) next generation risk model closes the loop on medical risk and resource evaluation, providing researchers with a tool to assess and choose capabilities scientifically. The Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT) simulator (SIM) evaluates resources in terms of medical benefit, such as reduced crew quality time lost (QTL), vs. cost, in mass or volume. The MEDPRAT resource set selector (SEL) searches the space of resource benefits v. cost, closing a feedback loop around the simulator, thus selecting resource sets with best benefit for cost. We discuss the design and results of the resource set selector. NASA HRP's emphasis on scientific assessment of risk, PRA, has led to the Cross-cutting Computational Modeling Project (CCMP).

Leinweber, Lawrence↗
NASA NTRS2020

Human Research Program Standard Measures in Analogs

To ensure that a minimal set of measures, relevant to human spaceflight risks, is consistently captured from subjects participating in spaceflight analog environments • The data from these measures will be placed in an archive managed by HRP and made available to studies via data sharing agreements • HRP Standard Measures will constitute a database for: – Providing context for data acquired by concurrent experiments – Supporting or developing hypotheses – Evaluating the effectiveness of various countermeasure profiles – Comparing population responses to various mission durations and scenarios

Clement, Gilles R.↗
NASA NTRS2019

Integrated Research Plan to Assess the Combined Effects of Space Radiation, Altered Gravity, and Isolation and Confinement on Crew Health and Performance: Problem Statement

Future crewed exploration missions to Mars could last up to three years and will expose astronauts to unprecedented environmental challenges. Challenges to the nervous system during these missions will include factors of: space radiation that can damage sensitive neurons in the central nervous system (CNS); isolation and confinement can affect cognition and behavior; and altered gravity that will change the astronauts’ perception of their environment and their spatial orientation, and will affect their coordination, balance, and locomotion. In the past, effects of spaceflight stressors have been characterized individually. However, long-term, simultaneous exposure to multiple stressors will produce a range of interrelated behavioral and biological effects that have the potential to adversely affect operationally relevant crew performance. These complex environmental challenges might interact synergistically and increase the overall risk to the health and performance of the astronaut. Therefore, NASA’s Human Research Program (HRP) has directed an integrated approach to characterize and mitigate the risk to the CNS from simultaneous exposure to these multiple spaceflight factors. The proposed research strategy focuses on systematically evaluating the relationships among three existing research risks associated with spaceflight: Risk of Acute (In-flight) and Late Central Nervous System Effects from Radiation (CNS), Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders (BMed), and Risk of Impaired Control of Spacecraft/Associated Systems and Decreased Mobility Due to Vestibular/Sensorimotor Alterations Associated with Spaceflight (SM). NASA’s HRP approach is intended to identify the magnitude and types of interactions as they affect behavior, especially as it relates to operationally relevant performance (e.g., performance that depends on reaction time, procedural memory, etc.). In order to appropriately characterize this risk of multiple spaceflight environmental stressors, there is a recognition of the need to leverage research approaches using appropriate animal models and behavioral constructs. Very little has been documented on the combined effects of altered gravity, space radiation, and other psychological and cognitive stressors on the CNS. Preliminary evidence from rodents suggest that a combination of a minimum of exposures to even two of three stressors of: simulated space radiation, simulated microgravity, and simulated isolation and confinement, have produced different and more pronounced biological and performance effects than exposure to these same stressors individually. Structural and functional changes to the CNS of rodents exposed to transdisciplinary combined stressors indicate that important processes related to information processing are likely altered including impairment of exploratory and risk taking behaviors, as well as executive function including learning, memory, and cognitive flexibility — all of which may be linked to changes in related operational relevant performance. The fully integrated research plan outlines approaches to evaluate how combined, potentially synergistic, impacts of simultaneous exposures to spaceflight hazards will affect an astronaut’s CNS and their operationally relevant performance during future exploration missions, including missions to the Moon and Mars. The ultimate goals are to derive risk estimates for the combined, potentially synergistic, effects of the three major spaceflight hazards that will establish acceptable maximum decrement or change in a physiological or behavioral parameters during or after spaceflight, the acceptable limit of exposure to a spaceflight factor, and to evaluate strategies to mitigate any associated decrements in operationally relevant performance.

Steinberg, Susan L.↗
NASA NTRSDate not supplied

Legume Organoleptic and Nutritional Analysis

Long-duration missions beyond low Earth orbit will encounter challenges in maintaining adequate nutrition and acceptability in the food system. In situ production of fresh produce can supplement nutrients deficient in the stored diet. Currently there is a limited number of crops that can be reliably grown for space crop production. Recent challenges with Veggie plant growth technical demonstrations (i.e. Tokyo Bekana Chinese cabbage interveinal chlorosis and necrosis when grown under elevated CO2 (~3000ppm) and narrow-band LED lighting) have highlighted the necessity to conduct rigorous ISS-relevant crop screening on the ground. Additionally, crops must be selected to address specific nutritional deficits as identified by HRP, with an emphasis on having a large diversity of crops available to meet nutritional requirements and crew acceptability. A variety of crop types are necessary to address known nutritional deficits in the stored astronaut diet, to include leafy greens (vitamin C, vitamin K, potassium), tomatoes and peppers (vitamin C, potassium, lycopene), and legumes (vitamin B1).Legumes are being evaluated for biological performance and suitability under ISS-like environmental conditions as well as nutritional content and acceptability. Legumes are one of the few pick and eat crop types that is an excellent source of Vitamin B1.In FY21-22 Biological and Physical Sciences (BPS) is funding screening of 32 legume crop cultivars at KSC, 16 of which will be down-selected based on horticultural performance and informal taste testing for further horticultural assessment and analysis. HRP in FY21-22 is funding organoleptic and nutritional analysis of these 16 down-selected legume cultivars to determine the most promising candidates for future space applications. Nutritional analysis will include full elemental, proximate (fat, protein, calories, carbohydrates, ash), and vitamins B1, C, K. This new work is currently postponed due to Covid-19.

L E Spencer↗
NASA NTRSDate not supplied

Human Factors and Behavioral Performance Exploration Measures Harmonized Across HERA, NEK, and ISS Teams Risk

The Human Factors and Behavioral Performance Exploration Measures (HFBP-EM) suite is a set of standardized measures to assess behavioral health and performance risk related to future exploration class missions, and to support reduction of the Human Research Program’s (HRP) Behavioral Medicine (BMed), Team, Sleep, and Human Systems Integration Architecture risks. HFBP-EM were collected during Human Exploration Research Analogs (HERA) campaigns 4 (C4) and 5 (C5), and during SIRIUS 17 and 19 missions in the Russian Ground Based Experiment Complex, NEK, to document the feasibility, flexibility, and acceptability of these measures in analogs of the spaceflight environment. A subset of the HFBP-EM suite was collected during spaceflight as part HRP’s Standard Measures in Spaceflight Project. Whenever possible, the HFBP-EM protocol and measures are kept the same across studies, however, differences across research settings (e.g., experimental manipulations, mission scenarios, mission length) and implementation of the measures require the data are harmonized to ensure comparable views across missions. The purpose of our project is to develop a harmonized database of HFBP-EM data from different settings, and to summarize the trajectory of behavioral health and performance within and between research settings. In this presentation, we will summarize the harmonized dataset and the trajectory of measures related to the Team Risk, including team performance, team cohesion, team processes, and psychological safety, over time and between and within settings.

S T Bell↗
NASA NTRSDate not supplied

Human Factors and Behavioral Performance Exploration Measures Harmonized Across HERA, NEK, And ISS: Behavioral Medicine Risk

The Human Factors and Behavioral Performance Exploration Measures (HFBP-EM) suite is a set of standardized measures used to assess behavioral health and performance risks related to future exploration class space missions. The HFBP-EM addresses the Human Research Program’s (HRP) Behavioral Medicine (BMed), Team, Sleep, and Human Systems Integration Architecture risks. HFBP-EM were collected during Human Exploration Research Analog (HERA) campaigns 4 and 5, and during SIRIUS 17 and 19 missions in the Russian Ground Based Experiment Complex, NEK, to document the feasibility, flexibility, and acceptability of these measures in analogs of spaceflight environments. A subset of the HFBP-EM suite was collected in spaceflight as part of the HRP Standard Measures in Spaceflight Project. Whenever possible, the HFBP-EM protocol and measures are the same across studies, differences across research settings (e.g., experimental manipulations, mission scenarios, and mission length) and implementation of the measures require that the data are harmonized to ensure comparable views across missions. The purpose of our project was to develop a harmonized database of analyzable HFBP-EM data from spaceflight and analog settings, and to summarize the trajectory of behavioral health and performance outcomes within and between mission settings. In this presentation, we will summarize the harmonized dataset and the trajectory of BMed related measures including depression, neurobehavioral function, mood, cognition, and operationally relevant individual performance over time and by campaign and mission.

S T Bell↗
NASA NTRSDate not supplied

Human Specimen Repository: Sample Collection for the Future [#133-000445]

In early 2014, an executive memo was released directing the improvement of the management of and access to scientific collections funded by government resources. In the spirit of this memo, NASA’s Human Research Program (HRP) funded a project to review existing residual samples in long-term storage for viability, identification, and scientific significance. These samples were to be collected in a centralized location and a detailed inventory was to be conducted to create the Human Sample Repository (HSR). HSR would work to review data from over 27,000 samples, from flight research projects dating back to 1998. The samples themselves would be reviewed, re-labeled, and organized into easy to retrieve, long-term storage. In addition to the older residual samples, HSR would expand to include pristine samples from all consenting crew who have flown on International Space Station (ISS) missions. All samples inventoried and managed by HSR are intended for the same purpose; to support future research projects which will utilize advanced technologies or techniques, by providing one-of-a-kind sample collections that can not be replicated. With this mission in mind, HSR will continue to collect residual samples from HRP funded projects and pristine samples from consenting crew, to further build this unique collection and increase the diversity of flight samples available to the scientific community.

Human Specimen Repository↗
NASA NTRSDate not supplied

From Here to There - Bird's Eye Perspective on Grant Lifecycle and Administration

“What gets measured gets done ”or “measure it to manage it”. The statements have become matter of fact. However, measurement (and even metrics) alone cannot fully communicate an organization’s story without the point of accountability. As a dynamic org, we must measure what is necessary, using the appropriate lenses to analyze the most relevant information that allows robust decision-making. A key function of Program Planning and Control (PP&C) is to assist HRP in the development of such strategy that ensures the proper execution of program research goals. With introspection of the Technical Officer role as defined by 2 CFR(i.e., Part 200, Part 1800)and subsequent governance under the NASA Grant and Cooperative Agreement Manual (GCAM), we’ve realized an obvious disconnect among Principal Investigator’s (PI),technical communication with the elements and some of the administrative/fiduciary requirements that should run parallel to the science work. This find has introduced new program risks as evidenced through incomplete deliverables or other less-than-successful requirements through the lifecycle for work we fund. One solution the Grants Technical Officer proposes is for PP&C to share in the communication with stakeholders of grants administration much earlier in the award process in attempt to reduce programmatic risks; particularly in data, reporting and performance management. As such, the planned IWS 2022 session will focus on(plenary) topics that include (1) definition of the grant lifecycle, (2) anatomy of a grant(NF1687 the award document), and (3)performance measurement/post-award monitoring. As HH&P pursues its strategic objectives to evolve the directorate into a data rich and knowledge rich organization, it has become increasingly important to develop the multiple levels of insight across the program to ensure data and other reporting(qualitative/quantitative), alongside proper administration. And the desired outcome is to make certain HRP meets/exceeds the accountability standard that our research information is received, maintained and accessible in posterity.

Lucy D Barnes-Moten↗
NASA NTRSDate not supplied

Development of A Crew Health and Performance System Probabilistic Risk Assessment Tool: Proof-of-Concept Approach

The crew health and performance (CHP) system represents the span of technological interventions and tested processes and procedures that in combination address the human risk to space flight. The Human Research Program (HRP) mental model of the CHP system breaks the capabilities needed to meet NASA human flight systems standards into specific categories (i.e., countermeasures, behavioral health, medical intervention). These categories are further broken down into specific sub-groups generally associated with the human system risks that these capabilities seek to mitigate. Like the approach used to develop the Integrated Medical Model (IMM) and the Medical Extensible Dynamic Probabilistic Risk Analysis Tool (MEDPRAT), HRP tasked NASA GRC’s Cross-Cutting Computational Modeling Project with developing a CHP probabilistic risk assessment tool, the CHP-PRA. The CHP-PRA model seeks to quantify and relatively assess the human risk state within the crew health and performance domain, using a combination of knowledge about human system risks and technology and practices likely to be applied during space flight missions. This modeling system will incorporate customer and stakeholder feedback and be flexible enough to address multiple different questions about important low-level mission-specific parameters. This presentation will introduce the initial concept and development timeline for this tool and demonstrate proof-of-concept through an application addressing a specific human risk question posed within the Artemis program.

Risk analysis↗
NASA NTRSDate not supplied

Preparation for an Earth Independent Medical Operations Demonstration using the Tempus ALS™ Medical Device

NASA’s exploration-class missions have severe resource constraints, long return trip durations, significant communication delays and limited resupply opportunities. Validation on the International Space Station (ISS) of medical devices that fit within Earth-Independent Medical Operations (EIMO) systems is a necessary preparation step. Key features of an EIMO medical system include: 1) technologies that support the prevention, diagnosis, and treatment of spaceflight medical events; 2) components that meet mass, volume, power and crew time/training constraints; 3) consideration of the medical skill level of the astronaut caregiver; 4) collection, storage and analysis of medical data within a central data architecture; and 5) incorporation of appropriate guidance and support tools that allow crew autonomy. The Human Research Program’s (HRP) Exploration Medical Capability (ExMC) Element and the Exploration Medical Integrated Product Team (XM-IPT) are planning an ISS technology demonstration to determine the feasibility of including a multifunctional medical device into an EIMO medical system. Demonstration Preparations: The Tempus ALS (Remote Diagnostic Technologies, Ltd., Philips Corp., Farnborough, UK) is a commercial-off-the-shelf medical device, with United States Food and Drug Administration clearance and is Conformité Européene marked in Europe. Several thousand units have been sold and are successfully operating in pre-hospital and in remote settings, such as by European Space Agency (ESA) flight surgeons and some of NASA’s commercial partners during post-flight medical operations. The Tempus ALS provides vital sign measurements such as blood pressure, electrocardiograms, heart rate, end tidal CO2, respiration rate, pulse oximetry and temperature. The device has ultrasound imaging and video laryngoscopy capabilities and has automatic or manual defibrillation modes for treating cardiac arrhythmias. It includes procedural guidance capabilities to assist in the collection of the vital sign measurements and it has various data transmission and report generation features. NASA’s HRP ExMC and XM-IPT are partnering with the ESA to demonstrate the Tempus ALS on ISS, with ESA manifesting the Tempus ALS and its accessories. ESA will compare performance of periodic health status exams and medical contingency drills performed nominally and with the Tempus ALS. NASA’s EIMO demonstration will include the use of Tempus ALS to diagnose a complaint of abdominal pain under increasingly independent circumstances. The caregiver must assess the present illness, collect vital sign measurements, and perform an abdominal ultrasound, under one of three communication situations, including real-time, with a several second delay and with a delay on the order of minutes. Expected Outcomes: Information will be gained about the feasibility, benefits, and challenges of using a multifunctional, all-in-one, medical device for medical diagnosis instead of separate devices with singular functionalities. Information will also be collected about performance differences as communication delays increase and available ground support decreases. Gaining this understanding will allow for further development of exploration medical system capabilities which takes the EIMO construct into consideration.

Beth Lewandowski↗
NASA NTRSDate not supplied

Summary of the virtual Space Radiation “2022 Biospecimen and Tissue Sharing Summit.”

The Space Radiation Element (SRE) of the Human Research Program (HRP) aims to establish a robust biospecimen and tissue sharing collection (BTSC) to improve sample collection, tracking, access, distribution, and usability to maximize scientific return with intention. Leveraging biospecimens and tissues from prior experiments helps HRP achieve its scientific goals to characterize and mitigate the human health impacts of spaceflight by maximizing resources. The project intends to expand on the National Aeronautics and Space Agency’s (NASA) current resources and institutional knowledge to provide ongoing modernization to improve the usability and access to the current biospecimen archive. SRE organized and held a three-day virtual workshop September 13-15, 2022, to engage with the research community with the following goals: - Share information about: - Space Radiation’s current Biospecimen and Tissue Sharing Project; - Software implementation to track biospecimens; - NASA’s current tissue sharing capabilities and projects; and - Collect community feedback on how to develop, streamline, and optimize accessible and usable processes. The first two days featured speakers internal and external to NASA who presented on current resources, best practices, lessons learned, and researcher perspectives. On the third day, a set of key questions were presented, and participants were invited to discuss and provide input.

Shelita Hall Augustus↗
NASA NTRSDate not supplied

Discovery Through Biospecimen Sharing: The Nasa Biological Institutional Scientific Collection (NBISC)

NASA Ames Research Center has fostered collaborations with other NASA centers, universities, and international space agencies by sharing non-human biospecimens from spaceflight and space-relevant ground experiments since the 1960s. These collaborations have advanced the field of space exploration by helping to maximize the data gained from spaceflight experiments. Non-human tissues archived from experiments funded by NASA’s Space Biology and Human Research Programs (HRP) are available for request through the NASA Life Sciences Portal (NLSP) and distributed by the NASA Biological Institutional Scientific Collection (NBISC). NBISC coordinates closely with the Ames Biospecimen Sharing Program (BSP) which is responsible for sample collection from spaceflight and ground experiments. NBISC currently houses more than 90,000 biospecimens in its facility at NASA Ames. Until recently, NBISC primarily distributed samples from Space Biology funded research. In 2022 NBISC partnered with HRP Space Radiation Element to also archive samples from studies which primarily involve rodents exposed to galactic cosmic radiation simulations at the NASA Space Radiation Laboratory (NSRL) and other analog facilities. In this presentation we will highlight several success stories of analyses carried out using archived NBISC samples received by researchers in recent years and will detail the process for proposing and receiving samples from NBISC. Making available these 90,000+ unique biospecimens to the scientific research community, NBISC not only functions as a resource for storing and distributing non-human biospecimens, but as a warehouse for future discoveries for the benefit of NASA and humankind.

NBISC↗
NASA NTRS2024

Optimizing Sample Collection and Accessibility through the Biospecimen and Tissue Sharing Collection (BTSC) Program

The Space Radiation Element (SRE) of the Human Research Program (HRP) is dedicated to establishing a robust biospecimen and tissue sharing collection (BTSC) program that enhances sample collection, tracking, access, distribution, and usability, with the goal of maximizing scientific return. By leveraging biospecimens and tissues from previous experiments, HRP effectively achieves its scientific objectives in characterizing and mitigating the human health impacts of spaceflight while optimizing resource utilization. To further improve the usability and accessibility of the current biospecimen archive, the project aims to expand upon NASA's existing resources and institutional knowledge, ensuring ongoing modernization. To facilitate seamless navigation of the program's workflow, an educational series on the BTSC program is provided to Principal Investigators (PIs). This comprehensive series equips PIs with crucial information on submitting their inventory via the BTSC Metadata Intake Form, ultimately leading to the public availability of their data on NASA's Life Science Portal (NLSP). Covering various aspects such as metadata submission instructions and backend processes for transferring metadata to the Laboratory Information Management System (LIMS), the series incorporates guidance from NASA's Biological Institutional Scientific Collection (NBISC) and Ames Life Sciences Data Archive (ALSDA). The BTSC program represents a significant stride towards enhancing the usability and accessibility of biospecimens for space research. By enabling NASA to deepen its understanding of the health implications of long-term spaceflight, this initiative plays a pivotal role in ensuring the safety and well-being of astronauts.

Shelita Renee Augustus↗
NASA NTRSDate not supplied

The NASA Biological Institutional Scientific Collection (NBISC): Tissue and Microbe Biospecimens to Advance Space Research

The NASA Biological Institutional Scientific Collection (NBISC) is a biorepository of non-human biospecimens from NASA-funded spaceflight investigations and correlative ground studies. The collection has its roots in the 1960s through collaborations by NASA Ames Research Center with other NASA centers, universities, and international space agencies by sharing non-human biospecimens from spaceflight and space-relevant ground experiments. These collaborations have advanced the field of space exploration by helping to maximize the data gained from spaceflight and other NASA-funded experiments. NBISC coordinates closely with the Biospecimen Sharing Program (BSP) which is responsible for organized sample collection from spaceflight and ground rodent experiments. In 2022 NBISC partnered with HRP’s Biospecimen and Tissue Sharing Collection (BTSC) Program to also archive samples from HRP’s Space Radiation Element-funded studies which primarily involve rodents exposed to various radiation protocols at the NASA Space Radiation Laboratory (NSRL) and other analog facilities. To date, more than fifty thousand biospecimens from BTSC have been transferred to NBISC for distribution to the community. In 2023, NBISC embarked on a new Space Biology funded endeavor to create the Space Microbial Culture Collection (SMCC) which will serve as a central repository for microbial isolates associated with space flight, gravitational, and space radiation research. This presentation will highlight several success stories of analyses carried out using archived NBISC samples received by researchers in recent years and will detail the process for proposing and receiving samples from NBISC, BTSC and SMCC. Making available these 150,000+ unique biospecimens to the scientific research community, NBISC not only serves as a repository for storing and distributing non-human biospecimens, but also acts as a resource to enable new discoveries that will benefit NASA and humankind.

Biospecimen↗
NASA NTRSDate not supplied

Medical Resource Set Bulky Item Trade Space Analysis for Spaceflight Medical Risk

The NASA engineering community utilizes event-driven and fault-tree probabilistic techniques to classify risks in the space environment by taking advantage of the inherent knowledge of complex spaceflight system design and testing to quantify failure risk. In harmonizing the risk of human space flight, answering the question of ‘How do we balance health, performance and resource risks with other engineering risks on long duration space missions?’ remains a deeply challenging and largely qualitative practice. The Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT) is one aspect of the efforts by NASA’s Human Research Program (HRP) to quantitatively assess the impact of health and performance risk. One of MEDPRAT’s key features is its high degree of computational efficiency. Coupled with the HRP High Performance Compute cluster located at NASA’s Glenn Research Center, MEDPRAT runs millions of simulated missions in a matter of minutes. This degree of computational efficiency provides the novel opportunity to explore the relationship between medical set mass, volume, and medical resource size. Of particular interest for future human spaceflight missions are ‘bulky’ items, medical resources like devices, which occupy a large portion of the small, allocated mass and volume for the medical set leaving less room for other resources. This talk will present results showing the quantitative impact of forced inclusion of several bulky items across a variety of medical kit constraints, and the effect that a potential research investment into reducing the bulky item mass and volume may have on risk.

Lauren Mcintyre↗
NASA NTRS2024

ISS Technology Demonstrations for Future Spaceflight Medical Systems

Throughout the history of human spaceflight, crewmembers have experienced various in-flight medical conditions including illness and injury. Planned missions to the Moon and Mars will require capabilities to maintain the health of future space travelers. Mass, power, and volume available in the vehicles and habitats for these missions will be severely constrained; resupply of resources will be limited or non-existent, as will opportunities for evacuation to Earth. Furthermore, ground-based support will be hampered by communication latencies and blackouts. These vehicle and mission constraints will necessitate a medical system that has been efficiently planned, providing on-board procedural guidance in addition to a variety of medical devices and consumable resources. Medical capabilities required for the diagnosis and treatment of potential medical conditions during future spaceflight missions may include real-time health monitoring, medical imaging, and biomarker analyses ( e.g., blood or urine). Terrestrial medicine shares these needs, thus many of these medical capabilities could likely be satisfied by Commercial-Off-The-Shelf (COTS) devices and methodologies; however, in some cases the unique space environment and increased mission duration will drive the need to modify technologies and the way care is provided. NASA’s Human Research Program (HRP) Exploration Medical Capability (ExMC) Element and Mars Campaign Office’s Exploration Medical Integrated Product Team (XMIPT) are working together to decrease medical risk during exploration missions. Flight-tested medical diagnostic and treatment technologies are necessary to effectively manage medical conditions relevant to exploration missions while meeting vehicle constraints, integrating with medical decision-support tools, and enabling increasingly Earth-independent operations. Several projects have leveraged the ISS as a testbed for exploration, including 1) i n- situ blood analysis, 2) medical inventory, 3) intravenous fluid generation, and 4) autonomous medical procedure guidance. Management of several in-flight medical conditions, such as bacterial and viral infections and acute radiation syndrome, is dramatically improved with ability to assess blood cell populations, electrolytes, and metabolites. I n December 2020 and January 2021 ExMC performed an ISS technology demonstration (Tech Demo) of the HemoCue® WBC DIFF analyzer (HemoCue, Brea, CA), a COTS device that was modified to enable functionality in a spaceflight environment. This Tech Demo marked the first time that hematology measurements were successfully performed real-time in microgravity. Also modified and demonstrated was the reusable Handheld Electrolytes and Lab Technology for Humans (rHEALTH) ONE analyzer (rHEALTH, Bedford, MA), which uses flow cytometry and sheath-based hydrodynamic focusing methodologies. The rHEALTH ONE ISS Tech Demo in May 2022 demonstrated test results obtained in-flight matched those on the ground. NASA currently relies on crew self-reporting to manage and maintain medical inventory on ISS.The ability to maintain an accurate inventory becomes more critical during long duration missions since the crew will need to be increasingly autonomous in finding and utilizing medical items, including those scenarios when alternative treatments need to be considered due to limited or no resupply. HRP’s Medical Consumables Tracking (MCT) project was developed by ZIN Technologies, Inc. (Cleveland, OH), and demonstrated real-time tracking of medical supplies aboard the ISS between December 2016 and July 2018. The MCT system design utilized Radio Frequency Identification Device (RFID) technology to perform automated inventory and was installed in the Crew Health Care System (CHeCS) Resupply Stowage Rack (RSR). The challenge of limited shelf life, exacerbated by the lack of resupply opportunities, affects a plethora of medical system components including consumables, pharmaceuticals, and intravenous (IV) fluid. In 2010, ExMC funded ZIN Technologies, Inc. (Cleveland, OH), to develop the Intravenous Fluid Generation (IVGEN) system. IV fluids were successfully generated with IVGEN using the potable water supply on ISS during ISS Expedition 23. The XMIPT is in the process of developing a miniaturized version of the original IVGEN hardware for a future Tech Demo aboard the ISS. Current ISS medical operations rely heavily on preflight training and real-time remote guidance, both of which become impractical or impossible for exploration missions. The primary goal of the Autonomous Medical Officer Support (AMOS) Software Tech Demos on ISS was to confirm telemedical proof-of-concept for autonomous medical imaging in an operational setting. This novel software tool shifts emphasis from preflight training and real-time remote guidance to in-flight just-in-time instruction, a new and necessary paradigm for crew medical autonomy. AMOS introduces a novel, streamlined skill management concept for exploration missions featuring comprehensive training and guidance modules for ultrasound examinations using the ISS Ultrasound 2 (a modified GE Vivid-q™; General Electric HealthCare, Chicago, IL). With no prior crew training or remote guidance, two Tech Demos on the ISS (April 2020 and June 2022) resulted in high quality, clinically useful image sets. We will provide a review of historical, current, and planned medical devices and technologies considered for inclusion within future spaceflight medical systems and summarize hardware development activities and medical device tech demos conducted on the ISS.

Astronaut health and performance↗
NASA NTRS2024

Lifetime Surveillance of Astronaut Health Newsletter

Welcome to the April 2024 issue of the Lifetime Surveillance of Astronaut Health (LSAH) Newsletter. In this issue, we celebrate LSAH lead, Dr. Mary Wear’s retirement, inform you of the Apollo Records Synthesis Project (ARSP), and recap information shared at the 2024 Human Research Program (HRP) Investigators’ Workshop (IWS) by our LSAH Epidemiologists and NASA HRP team.

Anna C. Morgenthaler-Cejka↗